FENOPRON
Live / Applied — Revived — awaiting further action (as of 11 Feb 2026)
What this means for you
Not registered yet, but its 14 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98699136
- Mark type
- Stylized text
- Filed
- 14 Aug 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Chelsea G. Swanson
Goods and services
- Class 005 — Pharmaceuticals: Analgesic preparations; Anti-inflammatory preparations; Pain relief medication; Pharmaceutical preparations for treating pain and inflammation
Owner
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
- Galt Pharmaceuticals, LLC, Atlanta, GA, US
Prosecution history
- 11 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 11 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 11 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 11 Feb 2026 — PETITION TO REVIVE-GRANTED
- 11 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 09 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jun 2025 — SOU EXTENSION 1 GRANTED
- 19 Jun 2025 — SOU EXTENSION 1 FILED
- 19 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED